Our mission is to help more than 400 million people with genetic diseases around the world.
The development of modern DNA sequencing methods has shifted the bottleneck in genomics away from sequencing.
Today interpretation of variants and identification of disease-causing mutations are the real bottleneck in genomics.
Our platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.
Our AI-driven variant interpretation platform AION automatically identifies likely pathogenic variants in less than 2 minutes.
AION helps you speed up large parts of your variant interpretation, focus on very complex cases, and grow sustainable business operations.
With our easy-to-use platform AION, we are changing the way labs can interpret genetic test results. So patients can get fast and accurate insight.
AION automatically identifies likely pathogenic variants in less than 2 minutes.
AION can improve diagnostic yield by more than 50% compared to a rules-based ACMG classification.
AION is based on a vast, regularly updated and extended database containing >100 annotations.
Denisa Weis, Assoc. Prof., MD, PhD.
Deputy Head of Institute
Institute of Medical Genetics Linz, Austria
„Swift evaluation with excellent success rate. Very practical to use.”
Dr. Andreas Laner
Head of Genomics
MGZ, Germany
“Naturally, the filtering and prioritisation of variants will continue to follow traditional workflows, but I am convinced that in the future we will improve our work with the help of intelligent machine-learning algorithms such as the Nostos AION.”
Thøger Krogh, PhD
Lead Bioinformatician
Amplexa Genetics A/S, Denmark
“The results were amazing, the datasets found exactly what we expected (and then some). Really impressive feat of you and your team."
